Navigation Links
Physicist Franz Pfeiffer receives 2011 Leibniz Prize
Date:12/2/2010

The DFG cited Pfeiffer's research in biomedical imaging, and in particular his pioneering work in X-ray phase-contrast imaging. His systematic approach has laid the foundation for applications of this technique in medicine and industry, where it is expected to deliver improved image contrast with lower doses of radiation. His research is recognized as having immense potential, from fundamental biophysical investigations to applications in medical imaging and diagnosis; it could bring about a marked shift in what is possible for mammography and computed tomography.

Before Pfeiffer's trail-blazing work, such X-ray phase-contrast imaging was only possible using the synchrotron X-ray sources available at large-scale research facilities. He developed a special methodology that made it possible to use normal X-ray sources for this purpose. He then showed that the newly developed approach could be combined with the methods of computed tomography to achieve previously unattainable levels of clarity and contrast in three-dimensional views into biomedical samples.

Particularly in the early detection of tumors, the analysis of phase-contrast information promises a marked improvement in diagnostic success, since the technique offers better contrast in soft tissue. To this end, the Center for Advanced Laser Applications (CALA) - a collaborative project of TUM and LMU -- has taken shape on the TUM campus Garching near Munich, with significant participation by physicist Pfeiffer and TUM Professor Michael Molls, a medical doctor. Molls is director of the Clinic for Radiation Therapy and Radiological Oncology at the university hospital Klinikum rechts der Isar.

TUM President Wolfgang A. Herrmann congratulated the new prize-winner: "You are not only one of our top scientists, but as a member of our Senate you also serve the overall development of the university. With your innovative contributions in X-ray physics, you are setting the direction for the CALA project and the medicine of tomorrow."

Professor Pfeiffer is the eighth scientist of the Technische Universitaet Muenchen to be honored with the Leibniz Prize. A further Leibniz Prize this year went to Professor Anja Feldmann, formerly of the Institute for Informatics at the TU Muenchen, now at the TU Berlin. Of the ten new Leibniz Prize-winners - four women and six men - four work in the biological sciences, three in physical sciences, two in engineering, and one in the humanities and social sciences. The prizes will be awarded in Berlin on March 16, 2011.


'/>"/>

Contact: Patrick Regan
regan@zv.tum.de
49-892-891-0515
Technische Universitaet Muenchen
Source:Eurekalert  

Related biology news :

1. Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue
2. How do bacteria swim? Brown physicists explain
3. Clemson physicist Apparao Rao named Fellow of the American Physical Society
4. Louisiana Tech physicists highlight top 10 science stories of 2008
5. Diamonds may be the ultimate MRI probe, say Quantum physicists
6. Rice physicists kill cancer with nanobubbles
7. Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light
8. Digging deep into diamonds, applied physicists advance quantum science and technology
9. CU physicists use ultra-fast lasers to open doors to new technologies unheard of just years ago
10. Biology may not be so complex after all, Emory physicist finds
11. NJIT physicist sees terahertz imaging as ultimate defense against terrorism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Physicist Franz Pfeiffer receives 2011 Leibniz Prize
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology: